About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(SMN1-SMN2*)16Cll
transgene insertion 16, Christian L Lorson
MGI:5490785
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Smn1tm1Msd/Smn1tm1Msd
Tg(SMN1-SMN2*)16Cll/0
Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb
involves: 129P2/OlaHsd * C57BL/6 * FVB/N MGI:5490787


Genotype
MGI:5490787
cx1
Allelic
Composition
Smn1tm1Msd/Smn1tm1Msd
Tg(SMN1-SMN2*)16Cll/0
Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Grm7Tg(SMN2)89Ahmb mutation (34 available); any Grm7 mutation (125 available)
Smn1tm1Msd mutation (37 available); any Smn1 mutation (87 available)
Tg(SMN1-SMN2*)16Cll mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mean lifespan is 34 days, with mutants living longer than double homozygous Smn1tm1Msd and Tg(SMN2)89Ahmb control mice
• nearly 25% of mutants live beyond 40 days, with several living beyond P70

growth/size/body
• smaller size compared to wild-type controls at P12, although weight is greater than in double homozygous Smn1tm1Msd and Tg(SMN2)89Ahmb control mice and some mutants eventually reach the weight of unaffected mice

behavior/neurological
N
• mutants are more agile and generally fitter than double homozygous Smn1tm1Msd and Tg(SMN2)89Ahmb control mice
• 20-70% of mutants at P5-15 are able to right themselves compared to 100% of unaffected control mice (mice homozygous for Tg(SMN2)89Ahmb and heterozygous for Smn1tm1Msd)
• starting at P5, mutants show increased ability to right compared to triple transgenics homozygous for Smn1tm1Msd and Tg(SMN2)89Ahmb and hemizygous for Tg(SMN2*delta7)4299Ahmb (20-70% vs. 3-15% in the controls)
• mutants stay on the rotorod for shorter periods of time than unaffected controls (mice homozygous for Tg(SMN2)89Ahmb and heterozygous for Smn1tm1Msd)
• mutants show a slight decrease in grip strength compared to unaffected controls (mice homozygous for Tg(SMN2)89Ahmb and heterozygous for Smn1tm1Msd)

muscle
• skeletal muscle fibers are smaller than in wild-type controls, however they are larger than in triple transgenics homozygous for Smn1tm1Msd and Tg(SMN2)89Ahmb and hemizygous for Tg(SMN2*delta7)4299Ahmb

nervous system
• mutants show an approximate 60% reduction of proprioceptive synapses onto motor neurons compared to triple transgenics homozygous for Smn1tm1Msd and Tg(SMN2)89Ahmb and hemizygous for Tg(SMN2*delta7)4299Ahmb
• P19 mutants show an increase in the percentage of neuromuscular junctions with perforated or fragmented endplates compared to controls homozygous for Tg(SMN2)89Ahmb, indicating a defect in synapse maturation
• mutants exhibit a modest but significant reduction in neuromuscular junction innervation in the longissimus muscle

cardiovascular system
• mutants show a slight reduction in interventricular septum thickness, although this does not reach significance
• the interventricular septum thickness is significantly improved compared to triple transgenic controls homozygous for Smn1tm1Msd and Tg(SMN2)89Ahmb and hemizygous for Tg(SMN2*delta7)4299Ahmb
• mutants exhibit a modest, but significant increase in cardiac interstitial fibrosis compared to unaffected wild-type controls
• interstitial fibrosis is significantly improved when compared to triple transgenic controls homozygous for Smn1tm1Msd and Tg(SMN2)89Ahmb and hemizygous for Tg(SMN2*delta7)4299Ahmb

integument
• mutants start to show signs of necrosis on the ears, tails, and/or eyes at approximately P40-P50

cellular
• mutants exhibit a modest, but significant increase in cardiac interstitial fibrosis compared to unaffected wild-type controls
• interstitial fibrosis is significantly improved when compared to triple transgenic controls homozygous for Smn1tm1Msd and Tg(SMN2)89Ahmb and hemizygous for Tg(SMN2*delta7)4299Ahmb

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Werdnig-Hoffmann disease DOID:13137 OMIM:253300
J:194969





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory